{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T10:41:11Z","timestamp":1720435271877},"reference-count":4,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,17]]},"DOI":"10.7759\/cureus.8671","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:09:17Z","timestamp":1592413757000},"source":"Crossref","is-referenced-by-count":2,"title":["Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?"],"prefix":"10.7759","author":[{"given":"Chelsea L","family":"Shover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"U.S. Food and Drug Administration warning letters. (2020). Accessed. April 30, 2020: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/compliance-actions-and-activities\/...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2019.305461","article-title":"Cannabis surveillance with Twitter data: emerging topics and social bots","volume":"110","author":"Allem JP","year":"2020","unstructured":"Allem JP, Escobedo P, Dharmapuri L. Cannabis surveillance with Twitter data: emerging topics and social bots. Am J Public Health. 2020, 110:357-362. 10.2105\/ajph.2019.305461","journal-title":"Am J Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305477","article-title":"The medical marijuana industry and the use of \u201cresearch as marketing\u201d","volume":"110","author":"Caputi TL","year":"2020","unstructured":"Caputi TL. The medical marijuana industry and the use of \u201cresearch as marketing\u201d. Am J Public Health. 2020, 110:174-175. 10.2105\/AJPH.2019.305477","journal-title":"Am J Public Health"},{"key":"ref4","article-title":"Deterrence and Crime Prevention (1st Edition), Routledge Studies in Crime and Economics","author":"Kennedy DM","year":"2009","unstructured":"Kennedy DM. Deterrence and Crime Prevention (1st Edition), Routledge Studies in Crime and Economics. Routledge, Oxford, UK; 2009."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/33916-debunking-cannabidiol-as-a-treatment-for-covid-19-time-for-the-fda-to-adopt-a-focused-deterrence-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:29Z","timestamp":1707506609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/33916-debunking-cannabidiol-as-a-treatment-for-covid-19-time-for-the-fda-to-adopt-a-focused-deterrence-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":4,"URL":"https:\/\/doi.org\/10.7759\/cureus.8671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,17]]}}}